WallStSmart

CME Group Inc (CME)vsValue Line Inc (VALU)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 20103% more annual revenue ($6.76B vs $33.45M). VALU leads profitability with a 64.7% profit margin vs 63.4%. VALU trades at a lower P/E of 16.8x. CME earns a higher WallStSmart Score of 55/100 (C-).

CME

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

VALU

Avoid

33

out of 100

Grade: F

Growth: 2.0Profit: 6.5Value: 6.0Quality: 8.5
Piotroski: 3/9Altman Z: 3.43

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.4%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Market CapQuality
$99.08B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

VALU5 strengths · Avg: 9.4/10
Profit MarginProfitability
64.7%10/10

Keeps 65 of every $100 in revenue as profit

Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
3.4310/10

Safe zone — low bankruptcy risk

Return on EquityProfitability
20.4%9/10

Every $100 of equity generates 20 in profit

P/E RatioValuation
16.8x8/10

Attractively priced relative to earnings

Areas to Watch

CME4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

EPS GrowthGrowth
2.5%4/10

2.5% earnings growth

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.782/10

Expensive relative to growth rate

VALU4 concerns · Avg: 2.8/10
Market CapQuality
$362.25M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
0.2%3/10

Operating margin of 0.2%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Revenue GrowthGrowth
-4.5%2/10

Revenue declined 4.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.4% and operating margin at 65.0%.

Bull Case : VALU

The strongest argument for VALU centers on Profit Margin, Debt/Equity, Altman Z-Score. Profitability is solid with margins at 64.7% and operating margin at 0.2%.

Bear Case : CME

The primary concerns for CME are Revenue Growth, EPS Growth, Piotroski F-Score.

Bear Case : VALU

The primary concerns for VALU are Market Cap, Operating Margin, Piotroski F-Score.

Key Dynamics to Monitor

CME profiles as a value stock while VALU is a declining play — different risk/reward profiles.

VALU carries more volatility with a beta of 1.02 — expect wider price swings.

CME is growing revenue faster at 0.8% — sustainability is the question.

CME generates stronger free cash flow (924M), providing more financial flexibility.

Bottom Line

CME scores higher overall (55/100 vs 33/100), backed by strong 63.4% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

Value Line Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

Value Line, Inc. produces and sells investment periodicals and related publications primarily in the United States. The company is headquartered in New York, New York.

Visit Website →

Want to dig deeper into these stocks?